Breakthrough cancer drug slows inflammation linked to heart disease
Experiments showed that the drug saracatinib reduced this inflammation signaling by more than 90% in human blood samples and diseased tissue
The Brighter Side of News features good news, compassionate news and inspirational news from around the world